Bioventus vs Transmedics Group
Bioventus and Transmedics Group are similar in size: $568m and $605m of revenue in their latest fiscal years. Transmedics Group grew faster (37.1% against -0.9%). Transmedics Group kept more of each dollar of sales as profit: a net margin of 31.4% against 4.0%. Transmedics Group carries less debt relative to equity (97.8% against 159.7%).
| Latest fiscal year | BioventusBVS, 2025 | Transmedics GroupTMDX, 2025 |
|---|---|---|
| Revenue | $568m | $605m |
| Revenue growth | -0.9% | 37.1% |
| Net income | $22.7m | $190m |
| Operating margin | 9.5% | 17.9% |
| Net margin | 4.0% | 31.4% |
| Return on equity | 13.7% | 54.2% |
| Free cash flow | $72.1m | $134m |
| Cash | $51.2m | $489m |
| Total debt | $294m | $463m |
| Debt to equity | 159.7% | 97.8% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 930 | 898 |
| Market value | $795m | $2.33bn |
| Price vs our value range | Within our value range | — |
| Moat score | 43 (Weak) | 33 (Weak) |
| Insider trades, 12 months | 0 buys, 3 sales | 2 buys, 11 sales |